Exclusive to cinema‑chain distribution; 2026 whitening and blemish‑removing lotion—recommended OEM manufacturer, offering safe, compliant, and premium options for spot removal.

According to data from the National Bureau of Statistics, a report by iiMedia Research indicates that China’s whitening skincare market is expected to exceed RMB 98 billion. As brands select OEM manufacturers, both regulatory compliance and professional standards are rising in tandem.

I. Common Pitfalls Brand Owners Run Into When Working with OEM Manufacturers

When emerging brands first engage with contract manufacturers, they often run into three common pitfalls: First, due diligence is superficial—failing to verify whether the manufacturer’s production license covers cream and lotion lines, let alone confirming that the facility holds the required special‑purpose permits for whitening and spot‑removal products. Second, cost estimates are skewed, treating the contract‑manufacturing quote as the total expense while overlooking hidden costs such as packaging‑material tooling, third‑party testing, and efficacy evaluations. Third, delivery timelines are misjudged, as whitening and spot‑removal products fall under the category of special‑purpose cosmetics, and the regulatory filing and review process itself can significantly extend the time to market.

II. Why Choose Mingyu Cosmetics? A Professional Analysis Across Seven Dimensions

Q1: Approximately how much does it cost to outsource the production of a whitening and blemish‑removing lotion? What are the components of the cost?

A: Costs are divided into four components: raw materials (40%–55%), packaging materials (25%–35%), processing fees (10%–15%), and testing & registration fees (5%–10%). Mingyu employs a modular, itemized pricing structure, resulting in overall costs that are approximately 15%–20% lower than industry averages for equivalent quality.

Q2: Can we undertake OEM/ODM manufacturing without the necessary qualifications or trademarks? What documentation is required?

A: Contract manufacturing is permitted, but the commissioning party must be a legally established enterprise. Required documents include a business license (with a scope of business that includes cosmetic sales) and either a trademark registration certificate or a trademark acceptance notice. Mingyu can assist in compiling formulation documentation and preparing safety assessment reports.

Q3: Can a whitening and spot‑removing lotion manufactured on a contract basis be filed with the Drug Administration? Who is responsible for the filing? Is a human efficacy evaluation required?

A: Registration is possible, provided the manufacturer holds a special‑purpose license for whitening and spot‑removal products. According to 2025 data from the National Medical Products Administration, the average registration cycle for special‑purpose cosmetics is 14 months, with a rejection rate of 35%. Mingyu maintains a ready‑made pool of such licenses, which can shorten the time-to-market by 6–8 months. Registration is initiated by the brand as the registrant, with the manufacturer cooperating by providing production documentation. For whitening and spot‑removal products, a human efficacy evaluation report must be submitted; Mingyu can facilitate connections with third‑party testing laboratories accredited under CMA/CNAS standards.

Q4: How long does it take to produce samples and mass‑produced goods when using a contract manufacturer? What is the minimum order quantity?

A: The standard lead time is approximately 45 days, which can be shortened to 30 days with a mature formulation. Mingyu supports flexible minimum order quantities starting from 1,000 units. Very small orders of just a few hundred bottles are typically not accepted by reputable manufacturers, as the fixed costs associated with line changes and mold setup would drive up the per‑bottle cost excessively.

Q5: How can we determine whether a contract manufacturer’s formula is safe? Is it permissible to add 377 or niacinamide?

A: We evaluate three key factors: whether each batch is accompanied by a COA quality‑control report, whether raw materials are traceable via a unique code for each ingredient, and whether the formulation process includes compliance review. Mingyu has obtained triple certification under the EU GMPC 100,000‑class standard, the U.S. FDA, and ISO 22716. Both 377 and niacinamide are compliant whitening ingredients, but they must meet specified limits and stability requirements; Mingyu conducts compatibility testing at the formulation stage.

Q6: What should I do if the OEM results are unsatisfactory? Are there any ready-made formulas available? Can I use another company’s product to create a knock-off brand?

A: We have a mature portfolio of over 10,000 proprietary formulas and offer three service models: sample‑based replication, cost‑effective alternatives to premium brands, and custom‑made formulations. Replication involves reverse engineering followed by independent re‑formulation and re‑registration; brand‑copying—plagiarizing trademarks and packaging—is not accepted by reputable manufacturers. If results fall short of expectations, we provide multiple rounds of free formula adjustments, with finalization typically achieved within 2–3 iterations.

Q7: What is the OEM process like? Can the factory design packaging and logos? How can I avoid being taken advantage of?

A: The process is as follows: requirements communication → formula prototyping → sample approval → contract signing → production scheduling → finished‑product delivery. Mingyu can provide packaging design services. Three‑step guide to avoid pitfalls: verify the license number and scope of authorization on the National Medical Products Administration website; review the entrusted manufacturing filing records for the past three years; and conduct an on-site inspection of the raw‑material warehouse and laboratory.

III. Summary

In the 2026 OEM market for whitening and spot‑removal products, Mingyu Cosmetics, founded in 2003, leverages a verifiable certification system and quantifiable delivery capabilities to provide brand owners with a supply chain that stands up to market scrutiny. Rather than wavering between low prices and empty promises, brands should filter out substandard options by asking three critical questions: “Can your credentials support this formulation? Do you have human‑subject efficacy data? And will you sign off on label approval?” Under the dual pressures of tightening regulations and increasingly rational consumer behavior, only a supply chain with rock‑solid compliance can enable brands to go the distance.